Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder

被引：5

作者：

Tikka, Sai Krishna ^{[1
]}

Garg, Shobit ^{[1
]}

Das, Basudeb ^{[1
]}

机构：

[1] Cent Inst Psychiat, Dept Psychiat, Ranchi, Jharkhand, India

来源：

INDIAN JOURNAL OF PHARMACOLOGY | 2013年 / 45卷 / 05期

关键词：

Induced manic switch; oculogyric dystonia; selective serotonin reuptake inhibitor; SEROTONIN REUPTAKE INHIBITORS; EXTRAPYRAMIDAL SYMPTOMS; ANTIDEPRESSANTS; TRANSPORTER;

D O I：

10.4103/0253-7613.117760

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Fluvoxamine has a similar spectrum of adverse effects as compared to other selective serotonin reuptake inhibitors. However, fluvoxamine induced oculogyric dystonia is a rare instance in clinical practice. In this report, we present a case of obsessive compulsive disorder that developed oculogyric dystonia during the course of fluvoxamine monotherapy and subsequently had a manic switch.

引用

页码：532 / 533

页数：2

共 50 条

[41] Comparison of the temperament between obsessive-compulsive disorder and idiopathic dystonia
Sumitani, S
Matsushita, M
Wada, K
Tomotake, M
Ueno, S
Yamashita, T
Matsumoto, S
Kaji, R
Ohmori, T
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S197 - S197
[42] Significant interaction of manic episodes with the clinical course of obsessive-compulsive disorder
Takasu, Yohei
Kitamura, Hideaki
Someya, Toshiyuki
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 64 (04) : 443 - 444
[43] Obsessive-compulsive disorder induced by donepezil in a patient with Alzheimer's disease
Echizen, Kohei
Hirose, Daisuke
PSYCHIATRY AND CLINICAL NEUROSCIENCES REPORTS, 2024, 3 (02):
[44] Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia
Kulkarni, Gajanan
Narayanaswamy, Janardhanan C.
Math, Suresh Bada
INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (05): : 649 - 650
[45] A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder
Milanfranchi, A
Ravagli, S
Lensi, F
Marazziti, D
Cassano, GB
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (03) : 131 - 136
[46] Neuroleptic-induced parkinsonism in patient with obsessive compulsive disorder: A case report
Nunes, J.
Brigadeiro, D.
Andrade, J.
Pissarra da Costa, A.
EUROPEAN PSYCHIATRY, 2017, 41 : S642 - S643
[47] FOCUS ON FLUVOXAMINE - A SEROTONIN REUPTAKE INHIBITOR FOR MAJOR DEPRESSION AND OBSESSIVE-COMPULSIVE DISORDER
STIMMEL, GL
SKOWRON, DM
CHAMEIDES, WA
HOSPITAL FORMULARY, 1991, 26 (08): : 635 - &
[48] 5HT-2 RECEPTOR AND FLUVOXAMINE EFFECT IN OBSESSIVE-COMPULSIVE DISORDER
ERZEGOVESI, S
RONCHI, P
SMERALDI, E
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1992, 7 (04) : 287 - 289
[49] SEROTONIN SYNDROME-LIKE SYMPTOMS IN A PATIENT WITH OBSESSIVE-COMPULSIVE DISORDER, FOLLOWING INAPPROPRIATE INCREASE IN FLUVOXAMINE DOSAGE
LENZI, A
RAFFAELLI, S
MARAZZITI, D
PHARMACOPSYCHIATRY, 1993, 26 (03) : 100 - 101
[50] EFFICACY OF FLUVOXAMINE IN OBSESSIVE-COMPULSIVE DISORDER - A DOUBLE-BLIND COMPARISON WITH PLACEBO
GOODMAN, WK
PRICE, LH
RASMUSSEN, SA
DELGADO, PL
HENINGER, GR
CHARNEY, DS
ARCHIVES OF GENERAL PSYCHIATRY, 1989, 46 (01) : 36 - 44

← 1 2 3 4 5 →